Johnson & Johnson Signs Licensing Deal for Kaken's Program for Autoimmune, Allergic Diseases
Johnson & Johnson (JNJ) Is Attracting Investor Attention: Here Is What You Should Know
Express News | J&J: Kaken Eligible to Get Equity Investment From Johnson & Johnson Innovation – Jjdc, Inc.
Express News | J&J: Gains Exclusive License to Kaken’s Stat6 Inhibitor Program, Including Lead Candidate Kp-723
Express News | J&J: To License Novel Oral Assets, Further Strengthening Commitment to Atopic Dermatitis
Top 7 Blue-Chip Stocks With The Best Return Potential Going Into 2025
loading...
loading...
loading...
105251507 : i thought u got lot of position??..what happen to soxl call?
ひな☆彡 SOXL(Bull) OP 105251507 : Just shared the stocks that I think will grow… I still have massive long call
ひな☆彡 SOXL(Bull) OP 105251507 : There you go, I did not want to tag all the stock because the title is which individual stock will grow
ひな☆彡 SOXL(Bull) OP : My entire position is on this post
Weekly Report W3 December
晴瓦林 : I believe the most reliable one are $SPDR Gold ETF (GLD.US)$ or $ProShares Ultra Gold (UGL.US)$
View more comments...